SCHEMBL20970306

SCHEMBL20970306

Cc1ccc2c(CC(C)(C)c3c(O)cccc3F)n[nH]c2c1C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20970353 0.80 CHRM2 (0.30) —
SCHEMBL20850536 0.76 MAPT (0.36) —
SCHEMBL2492055 0.70 TRPA1 (0.44) —
SCHEMBL22328040 0.69 — —
SCHEMBL21734001 0.67 NOS1 (0.32) —
SCHEMBL17030765 0.66 ADORA2A (0.35) —
SCHEMBL20132850 0.65 CHEK1 (0.41) —
SCHEMBL20807053 0.64 RIPK1 (0.39) —
SCHEMBL22924129 0.64 — —
SCHEMBL17030769 0.64 ADORA2A (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10822312-B2 Substituted quinazoline compounds and methods of use ARAXES PHARMA LLC (US) 2020-11-03 — — US disclosed
US-20190127336-A1 SUBSTITUTED QUINAZOLINE COMPOUNDS AND METHODS OF USE ARAXES PHARMA, LLC 2019-05-02 — — US disclosed
Send feedback